Akanda (NASDAQ:AKAN) Downgraded by Wall Street Zen to “Strong Sell”

by · The Cerbat Gem

Wall Street Zen cut shares of Akanda (NASDAQ:AKAN – Free Report) from a sell rating to a strong sell rating in a research note released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Akanda in a report on Thursday, August 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

Read Our Latest Research Report on Akanda

Akanda Stock Performance

AKAN opened at $3.89 on Friday. Akanda has a 1-year low of $2.30 and a 1-year high of $209.02. The firm has a 50-day moving average price of $8.20 and a two-hundred day moving average price of $10.10.

Akanda (NASDAQ:AKAN – Get Free Report) last released its quarterly earnings results on Tuesday, June 9th. The company reported ($317.90) EPS for the quarter.

Akanda Company Profile

(Get Free Report)

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Read More